Genetic and Genomic Characterization of the Occurence and Progression of Interstitial Lung Abnormalities02/01/2024 - 11/30/2027 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI2R01HL135142-05A1
Clinical Center for NIH's Nurtrition for Precision Health: The All of Us NEw England Research Collaborative12/10/2021 - 11/30/2026 (Subcontract PI)
Trustees of Tufts College, Inc NIH NICHD5UG1HD107691-03
Framingham Heart Study04/01/2019 - 06/30/2025 (Multi-PI)
PI:
George T. O'Connor, MDNIH/National Heart, Lung, and Blood Institute
The New England Precision Medicine Consortium of the All of Us Research Program03/01/2019 - 05/31/2025 (Multi-PI)
PI:
George T. O'Connor, MDMassachusetts General Hospital NIH OD3OT2OD026553-01S4
Childhood Asthma in Urban Settings (CAUSE)- Leadership Center08/01/2021 - 03/31/2025 (Subcontract PI)
University of Wisconsin, Madison NIH NIAID5UM1AI160040-04
The Boston University Clinical and Transitional Science Institute04/15/2020 - 03/31/2025 (Key Person)
PI:
Megan H. Bair-Merritt, MD, MSCENIH/National Center for Advancing Translational Sciences5UL1TR001430-09
Multi-Omic Approaches To Mechanisms Of Vitamin D, Environmental Influences, And The Microbiome On Asthma09/01/2018 - 08/31/2023 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH OD5UH3OD023268-07
Childrens Respiratory and Environmental Workgroup (CREW)09/01/2018 - 08/31/2023 (Subcontract PI)
University of Wisconsin System NIH OD5UH3OD023282-07
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences05/01/2019 - 04/30/2023 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI5R01HL111024-09
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities08/01/2018 - 07/31/2021 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI5R01HL135142-04
Showing 10 of 39 results.
Show All Results
Inner City Asthma Consortium 3 (ICAC3)08/01/2016 - 07/31/2021 (Subcontract PI)
University of Wisconsin System NIH NIAID3UM1AI114271-07S1
Childrens Respiratory and Environmental Workgroup (CREW)09/01/2018 - 08/31/2019 (Subcontract PI)
University of Wisconsin, Madison NIH OD4UH3OD023282-03
Randomized Controlled Trial: VDAART CONTINUATION STUDY - DCC - LEAD05/15/2014 - 04/30/2019 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI5R01HL091528-10
Children's Respiratory and Environmental Workgroup (CREW), CREW Year 209/01/2017 - 08/31/2018 (Subcontract PI)
University of Wisconsin, Madison NIH OD5UG3OD023282-02
Children's Respiratory and Environmental Workgroup (CREW) CREW Year 209/01/2017 - 08/31/2018 (Subcontract PI)
University of Wisconsin, Madison NIH OD5UG3OD023282-02
Multi-Omic Approaches To Mechanisms Of Vitamin D, Environmental Influences, And The Microbiome On Asthma09/21/2016 - 08/31/2018 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH OD5UG3OD023268-02
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences07/01/2016 - 06/30/2018 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI5R01HL111024-05
Inner City Asthma Consortium 3 (ICAC3)08/05/2014 - 07/31/2017 (Subcontract PI)
University of Wisconsin System NIH NIAID5UM1AI114271-03
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences07/01/2015 - 06/30/2017 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI5R01HL111024-03
A New England Enrollment Center for the PMI Cohort Program09/27/2016 - 03/31/2017 (Multi-PI)
PI:
George T. O'Connor, MDMassachusetts General Hospital NIH OD1OT2OD024612-01
Transcriptomic and Epigenetic Signatures of Tobacco Exposure02/01/2015 - 01/31/2017 (PI)
American Heart Association
VDAART FLORA ANCILLARY STUDY04/01/2011 - 03/31/2015 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI5R01HL108818-03
The Framingham Heart Study: Physical Examinations, Testing and Surveillance02/01/2002 - 03/31/2015 (PI of Sub-Project / SP)
PI:
Philip A. Wolf, MDNIH/National Heart, Lung, and Blood InstituteN01-HC-25195
Vitamin D Supplementation in Pregnancy: Impact on Neonatal Immune Phenotype02/16/2010 - 12/31/2014 (PI)
NIH/National Heart, Lung, and Blood Institute5R01HL101390-04
Inner-City Asthma Consortium(ICAC)-Immunologic Approaches to Reduce Asthma CORE09/29/2009 - 09/29/2014 (Subcontract PI)
University of Wisconsin System NIH NIAID
Vitamin D Antenatally for Asthma Reduction Trial (VDAART)03/01/2009 - 05/14/2014 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI5U01HL091528-05
VDAART Flora Ancillary Study04/01/2011 - 03/31/2014 (PI)
Brigham & Women's Hospital NIH NHLBI
Boston University Clinical and Translational Science Award (CTSA) Program UL105/01/2008 - 04/30/2013 (Key Person)
PI:
David M. Center, MDNIH/National Center for Health Research Resources3UL1RR025771-04
Sleep Heart Health Study09/30/1999 - 08/31/2009 (PI)
NIH/National Heart, Lung, and Blood Institute 5 U01 HL53941 14
Asthma Control Evaluation (ACE): A Biomarker-Based Approach to Improving Asthma Control11/01/2003 - 09/30/2006 (PI)
University of Wisconsin NIH NIAID
Epidemiology of IL-16 Polymorphism and Asthma Severity08/01/2003 - 07/31/2005 (Co-PI)
NIH/National Heart, Lung, and Blood Institute1 F32 HL74571 01
Trial of Interventions to Reduce Asthma Morbidity08/01/1996 - 07/31/2005 (PI)
NIH/National Institute of Allergy & Infectious Diseases5 U01 AI39769 05
Analysis of Lipids, Inflammation, and Pulmonary Function03/15/2002 - 02/28/2005 (PI)
NIH/National Heart, Lung, and Blood Institute5 R03 HL70289 02
Inspire 01-312 A Double Blind, Placebo Controlled, Parallel Group Study of Uridine 5’-Triphosphate (UTP)07/15/2003 - 12/31/2004 (Co-PI)
PI:
Helen M. Hollingsworth, MDInspire Pharmaceuticals Inc
Clinical Centers for Feasibility Studies of Retinoid Treatment in Emphysema (FORTE)09/30/1999 - 12/31/2004 (PI)
NIH/National Heart, Lung, and Blood InstituteN01 HR 96141
Evaluation of Home Asthma Telemonitoring (HAT) in Adults09/01/2003 - 07/31/2004 (PI)
University of Maryland NIH NHLBI
Revision of ATS-DLD Respiratory Disease Questionnaire06/15/2000 - 05/31/2004 (PI)
NIH/National Heart, Lung, and Blood Institute1 R13 HL65718 01
Effects of 12 Week Treatment of 5 25 or &5 Mg BIIL 284 BS on Exercise Endurance in Patients with Chronic Obstructive Pulmonary Disease Double Blind Double Dummy Placebo Controlled Randomized Parallel Group Dose Ranging Study11/01/2001 - 10/31/2002 (PI)
Boehringer Ingelheim Pharmaceuticals
Anxiety and Cardiovascular Autonomic Control02/01/1998 - 01/31/2001 (PI)
Brigham & Women's Hospital NIH NHLBI
PRE-NOTIFICATION ACCOUNT The New England Precision Medicine Consortium of the All of Us Research Program06/01/2024 - 05/31/2025 (Subcontract PI)
PI:
George T. O'Connor, MDThe General Hospital Corporation / MGH NIH
The New England Precision Medicine Consortium of the All of Us Research Program03/01/2018 - 05/31/2024 (Subcontract PI)
PI:
George T. O'Connor, MDThe General Hospital Corporation / MGH NIH
A New England Enrollment Center for PMI Cohort Program (All of Us Research Program AURP)04/01/2017 - 07/31/2017 (Subcontract PI)
PI:
George T. O'Connor, MDThe General Hospital Corporation / MGH NIH
ScreenFlow - COPD Screening System09/30/2014 - 09/29/2016 (PI)
Dimagi, Inc. NIH-DHHS
ScreenFlow - COPD Screening System07/01/2012 - 11/07/2013 (PI)
Dimagi, Inc. NIH-NHLBI
Screen Flow Development - Research Assistance12/21/2012 - 05/31/2013 (PI)
Dimagi, Inc.